Antivertigo agents. IV. Synthesis and antivertigo activity of 6-[omega-(4-aryl-1-piperazinyl)alkyl]-5,6,7,8-tetrahydro-1,6-naphth yridines.
D000818:Animals; D000932:Antiemetics / Q000138:chemical synthesis*; D001058:Apomorphine; D002415:Cats; D055598:Chemical Phenomena; D002621:Chemistry; D004285:Dogs; D009287:Naphthyridines / Q000138:chemical synthesis*; D009760:Nystagmus, Physiologic / Q000187:drug effects; D010879:Piperazines / Q000138:chemical synthesis*; D014717:Vertigo / Q000188:drug therapy*; D014839:Vomiting / Q000139:chemically induced / Q000517:prevention & control
D000932:Antiemetics; D009287:Naphthyridines; D010879:Piperazines; D001058:Apomorphine